Previous close | 6.2000 |
Open | 4.0200 |
Bid | 2.2500 |
Ask | 4.2000 |
Strike | 110.00 |
Expiry date | 2024-11-15 |
Day's range | 4.0200 - 4.0200 |
Contract range | N/A |
Volume | |
Open interest | 339 |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.